Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1996 | 12-1995 | 12-1994 | 12-1993 | 12-1992 | |
| Gross Profit | 38,667 | N/A | N/A | N/A | N/A |
| Operating Expenses | 14,154 | 0 | 0 | 0 | 0 |
| Operating Income | -14,154 | N/A | N/A | N/A | N/A |
| Pre-tax Income | -14,154 | 0 | 0 | 0 | 0 |
| Net Income Continuous | -14,154 | N/A | N/A | N/A | N/A |
| Net Income | $-14,154 | $N/A | $N/A | $N/A | $N/A |
| EBITDA(a) | $-7,303 | $N/A | $N/A | $N/A | $N/A |